[Determination of functional activity of lymphocytes in patients with tuberculosis and in patients of group IIIA of clinic registries by electrophoretic mobility].
Morozova. T I TI; Khudzik. L B LB; Tikhomirova. L A LA
Key Findings
- TB patients and those with lingering lung changes show abnormal lymphocyte activity
- Thymalin (or similar thymic peptide) restored functional activity of T and B cells
- Thymalin improved tolerance to anti‑TB chemotherapy in the studied group
Practical Outcomes
- For biohackers, thymalin appears to have immune‑enhancing properties, but evidence is confined to tuberculosis contexts. It’s not a proven anti‑aging or performance aid for healthy people, and more studies are needed before recommending it as a routine supplement.
Summary
The study looked at people with active or past tuberculosis and found their immune cells behaved oddly. Giving them a thymus‑derived peptide called thymalin helped normalize immune cell activity and made them handle follow‑up chemotherapy better. This suggests thymalin can boost certain immune functions, but the research is limited to TB patients, not healthy folks.
Abstract
The electrophoretic mobility of peripheral blood lymphocytes was studied in 35 patients with pulmonary tuberculosis, 128 persons clinically cured of tuberculosis, and 30 healthy persons by using an Elphor-VaP-5 apparatus (Germany). This study revealed abnormal lymphocytic functional activity both in patients with tuberculosis and in patients with great residual changes after prior tuberculosis, which was the basis for using of thymic immunomodulators (thymalin or thymogen) in the latters. Immunomodulators improved the tolerance of antirecurrent chemotherapy in persons with IIIA dispensary register group and produced a marked stimulating effect on the functional activity of T and B lymphocytes.
Study Information
pubmed
1994